Also, basal-like triple-negative and HER2+ breast tumors express large amounts of GLS, whereas luminal B tumors have elevated levels than luminal B tumors (36), and the deregulation of glutaminolysis by GLS knockdown induces breast tumor growth inhibition (37). Here, ERBB2 is linked to breast neoplasm.